Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Hire More Ex-Company Employees: Dr Aoki
January 21, 2008
- Takeda, Daiichi Sankyo Files NDAs for Their Future Blockbusters in the US
January 21, 2008
- REGULATORY NEWS IN BRIEF
January 21, 2008
- Meiji Seika Aims at \10 Bil. Sales with Generics
January 21, 2008
- NEW PRODUCTS／Dinagest Tablet for Endometriosis: Mochida
January 21, 2008
- Taisho Licenses TS-032 to Pfizer
January 21, 2008
- Tacere to Codevelop RNAi Hepatitis C Drug with Pfizer
January 21, 2008
- Mochida Licenses Analgesic to Wyeth
January 21, 2008
- Toyama Starts PII Study for T-705
January 21, 2008
- Novartis to Close Its Tsukuba Research Institute
January 21, 2008
- REGULATORY NEWS IN BRIEF
January 14, 2008
- Complete Lifting of Ban on Kongyo Shinryo Not Recommended by Council
January 14, 2008
- Non-Tamiflu Users Show Higher Incidence of Abnormal Behavior: Study Team Report
January 14, 2008
- ON THE MOVE／J&J Appoints D. W. Powell President
January 14, 2008
- Abnormal Behavior Reported in 38% of Patients Not Taking Tamiflu
January 14, 2008
- R&D NEWS IN BRIEF
January 14, 2008
- Nexavar, Licomodulin, Zevalin to Be Officially Approved Soon
January 14, 2008
- Korosho's General Account Budget to Total \22,117.9 Bil.
January 14, 2008
- Korosho to Promote the Use of Generics by Welfare Recipients
January 14, 2008
- Rules to Be Revised to Oblige Pharmacists to Dispense Generics: Mr Urushibata
January 14, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…